BlackRock, Inc. 13D and 13G filings for Cogent Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-21 3:47 pm Unchanged | 2025-12-31 | 13G | COGENT BIOSCIENCES INC COGT | BlackRock Inc. BLK | 11,370,224 6.500% | 0 (Unchanged) | Filing |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | COGENT BIOSCIENCES INC COGT | BlackRock Inc. BLK | 11,370,224 6.500% | 4,614,640 (+68.31%) | Filing |
| 2024-01-26 11:49 am Purchase | 2023-12-31 | 13G | COGENT BIOSCIENCES INC COGT | BlackRock Inc. BLK | 6,755,584 7.800% | 1,809,141 (+36.57%) | Filing |
| 2023-02-03 12:10 pm Purchase | 2022-12-31 | 13G | COGENT BIOSCIENCES INC COGT | BlackRock Inc. BLK | 4,946,443 7.100% | 1,649,663 (+50.04%) | Filing |
| 2022-07-08 4:57 pm Purchase | 2022-06-30 | 13G | COGENT BIOSCIENCES INC COGT | BlackRock Inc. BLK | 3,296,780 3.800% | 598,126 (+22.16%) | Filing |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | COGENT BIOSCIENCES INC COGT | BlackRock Inc. BLK | 2,698,654 6.800% | 1,204,551 (+80.62%) | Filing |